KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Return on Invested Capital (2016 - 2025)

Globus Medical's Return on Invested Capital history spans 14 years, with the latest figure at 0.1% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 6.0% year-over-year to 0.1%; the TTM value through Dec 2025 reached 0.1%, up 6.0%, while the annual FY2025 figure was 0.09%, 6.0% up from the prior year.
  • Return on Invested Capital reached 0.1% in Q4 2025 per GMED's latest filing, up from 0.08% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.11% in Q2 2021 to a low of 0.01% in Q2 2024.
  • Average Return on Invested Capital over 5 years is 0.07%, with a median of 0.08% recorded in 2022.
  • Peak YoY movement for Return on Invested Capital: fell -9bps in 2024, then grew 6bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.08% in 2021, then increased by 20bps to 0.1% in 2022, then tumbled by -76bps to 0.02% in 2023, then rose by 28bps to 0.03% in 2024, then skyrocketed by 206bps to 0.1% in 2025.
  • Per Business Quant, the three most recent readings for GMED's Return on Invested Capital are 0.1% (Q4 2025), 0.08% (Q3 2025), and 0.06% (Q2 2025).